Analysts anticipate Vertex Pharmaceuticals to report an earnings per share (EPS) of $4.31. Anticipation surrounds Vertex Pharmaceuticals's announcement, with investors hoping to hear about both ...

Has Polar done enough with the Grit X2 Pro to rival Garmin's Fenix running watch? The post Polar Grit X2 Pro review: kept ...

Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 10 years ago, it would be worth $3,986.54 today based on ...